Cargando…
Partial mGlu(5) Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG
Selective negative allosteric modulators (NAMs) targeting the metabotropic glutamate receptor subtype 5 (mGlu(5)) demonstrate anxiolytic-like and antidepressant-like effects yet concern regarding adverse effect liability remains. Functional coupling of mGlu(5) with ionotropic N-methyl-D-aspartate re...
Autores principales: | Holter, Kimberly M., Lekander, Alex D., LaValley, Christina M., Bedingham, Elizabeth G., Pierce, Bethany E., Sands, L. Paul, Lindsley, Craig W., Jones, Carrie K., Gould, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283128/ https://www.ncbi.nlm.nih.gov/pubmed/34276300 http://dx.doi.org/10.3389/fnins.2021.700822 |
Ejemplares similares
-
mGlu(5) Positive Allosteric Modulators Facilitate
Long-Term Potentiation via Disinhibition Mediated by mGlu(5)-Endocannabinoid Signaling
por: Xiang, Zixiu, et al.
Publicado: (2019) -
Allosteric Modulators for mGlu Receptors
por: Gasparini, F, et al.
Publicado: (2007) -
Discovery of a Novel Chemical Class of mGlu(5) Allosteric Ligands with Distinct Modes of Pharmacology
por: Hammond, Alexis S., et al.
Publicado: (2010) -
Tetrahydronaphthyridine and
Dihydronaphthyridinone
Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate
Receptor 5 (mGlu(5))
por: Turlington, Mark, et al.
Publicado: (2014) -
Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers
por: Wang, Xinwei, et al.
Publicado: (2023)